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Abstract
Radiographic patterns on CT chest scans have shown higher sensitivity and specificity compared to RT-PCR detection of
COVID-19 which, according to the WHO has a relatively low positive detection rate in the early stages. We technically review
a study that compared multiple convolutional neural network (CNN) models to classify CT samples with COVID-19, Influenza
viral pneumonia, or no-infection. We compare this mentioned study with one that is developed on existing 2D and 3D deeplearning models, combining them with the latest clinical understanding, and achieved an AUC of 0.996 (95%CI: 0.989–1.00) for
Coronavirus vs Non-coronavirus cases per thoracic CT studies. They calculated a sensitivity of 98.2% and a specificity of 92.2%.
Keywords Pandemic . Viral pneumonias . Convolutional neural networks . Deep learing

1 Introduction
In December 2019 the SARS-CoV-2 zoonotic virus, originating from the Phinolophus bat, was transmitted to humans, for
the first time recorded. The Huanan Seafood Wholesale
Market in Wuhan City, Hubei Province, China, was the epicenter of the coronavirus disease (COVID-19) outbreak
caused by SARS-CoV-2, which rapidly spread worldwide
and was declared a pandemic by WHO on 11th March 2020
[1]. COVID-19 has led to complications such as acute respiratory disorder, heart problems, and secondary infections in a
relatively high proportion of patients and thus significant mortality. Early detection and commencement of treatment in severe cases is key to reducing mortality [1].
Radiographic patterns on CT chest scans have shown
higher sensitivity and specificity compared to RT-PCR detection of COVID-19 which, according to the WHO has a relatively low positive detection rate in the early stages. One report, of 1041 cases from China, found that sensitivity of
COVID-19 detection on chest CT was 97% (95%CI, 95–
98%, 580/601 patients) based on positive RT-PCR results
[2]. CT chest images for COVID-19 positive cases have a
distinct radiographic pattern: ground-glass opacities, multifocal patchy consolidation, and/or interstitial changes with a
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predominantly peripheral distribution [2, 3]. A study of 21
patients with the 2019 novel coronavirus, found that 15
(71%) had involvement of more than two lobes at chest CT,
12 (57%) had ground-glass opacities, seven (33%) had opacities with rounded morphology, seven (33%) had a peripheral
distribution of disease, six (29%) had consolidation with
ground-glass opacities, and four (19%) had crazy-paving pattern. No lung cavitation, discrete pulmonary nodules, pleural
effusions, and lymphadenopathy were seen. Fourteen percent
of patients (three of 21) presented with a normal CT scan [3].
Information and CT scans are available from this current outbreak, which shows the evolvement of lung opacities over
time, from symptom onset to 41 days from onset (Fig. 1), in
a COVID-19 positive patient [4].
The characteristic manifestations of COVID-19 in CT
scans can make it distinguishable from other viral types of
pneumonia: though not reliable solely based on human observation due to the overlap of certain manifestations with other
viral pneumonia [4] (see Table 1). However, with the use of AI
and deep learning technologies it is possible to accurately
differentially diagnose between the viral types of pneumonia,
making it an effective screening tool. We review here, one
such study, which compared multiple convolutional neural
network (CNN) models to classify CT samples with
COVID-19, Influenza viral pneumonia, or no-infection [7].
Given a large number of COVID-19 cases in China, it has
been an area of experimental development for emerging deep
learning technology companies. This pandemic may provide
large CT data sets to train on and obtain accurate COVID
recognition. Worldwide, a shared national CT chest database
is necessary to train the AI model with accurate generalizable
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Fig. 1 CT chest images of a COVID-19 positive patient over time. a Day
7 (after the onset of symptoms): scan shows opacities in the left lower and
right upper lobes. b and c Day 9: scans show multifocal bilateral groundglass opacities. d Day 15: The scan shows evolution to a mixed pattern of
ground-glass opacities and consolidation. e Day 19: scan shows healing

of the consolidations and ground-glass opacities due to treatment with
antivirals. f Day 31: The scan shows complete resolution. Absence of
pulmonary cavitation, pleural effusions, and lymphadenopathy noted in
our data, was also characteristic of previous SARS studies, from Shi et al.
[4]

large population results during this pandemic. These deep
learning techniques can assist physicians in detecting and
guiding treatment management.

Every COVID-19 patient was confirmed with RT-PCR testing
kit and the cases that had no image manifestations on the chest
CT images were excluded. Also, there had at least two days
gap between CT datasets if taken from the same patient to
ensure the diversity of samples. The remaining 399 CT samples were collected as the controlled experiment group.
Among them, 224 CT samples were from 224 patients with
Influenza-A viral pneumonia including H1N1, H3N2, H5N1,
H7N9, etc., and 175 CT samples from healthy people. There
were 198 (90.4%) COVID-19 and (196) 86.6% Influenza-A
cases from early or progressive stages and the rest 9.6% and

2 Methods
2.1 Dataset introduction
A total of 618 transverse-section CT samples were collected in
this study, including 219 from 110 patients with COVID-19.
Table 1

Characteristics of four common respiratory viral infections (adapted from [5, 6])
Typical CT Findings
Incubation Transmission
(days)

Human corona
2–10
(SARS-CoV2)
Adenovirus
4–8

RSV

3–7

Droplet, airborne,
contact
Respiratory,
oral-fecal,
conjunctival
Contact, aerosol

Influenza

1–4

Droplet, airborne

Distribution

Consolidation GGO Nodule

Bronchial wall Pleural
thickening
effusion

Systemic
involvement

UC

Rare

Not definite

Periph-eral, +++
multifocal
Multifocal
+++

+

Rare

+++

Centrilobular UC
+

C

Not definite

Airway

+

+

C

Not definite

Airway,
Multifocal

+

+

Centrilobular C
+++
++
C

UC

Not definite
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13.4% cases from severe stage respectively (P > 0.05).
Moreover, Influenza-A viral pneumonia CT cases were included as it was critical to be able to distinguish them from
suspected patients with COVID-19, with the current situation
in China.
A total of 528 CT samples (85.4%) were used for training
and validation sets, including 189 samples of patients with
COVID-19, 194 samples from patients with Influenza-A viral
pneumonia, and 145 samples from healthy people. The remaining 90 CT sets (14.6%) were used as the test set, including 30 COVID-19, 30 Influenza-A viral pneumonia, and 30
healthy cases. Furthermore, the test cases of CT set were selected from people who had not been included in the training
stage.

2.2 Process
Figure 2 below, shows the process of COVID-19 diagnostic
report generation in this study. To sum up, first, the CT images
were preprocessed to extract effective pulmonary regions.
Second, a 3D CNN model was used to segment multiple candidate image cubes. The center image, together with the two
neighbors of each cube, was collected for further steps. Third,
an image classification model was used to categorize all image
patches into one of three types: COVID-19, Influenza-A-viralpneumonia, and irrelevant-to-infection. Image patches from
the same cube voted for the type and confidence score of the
candidate as a whole. Finally, the overall analysis report for
one CT sample was calculated using the Noisy-or Bayesian
function.

Fig. 2 Process flow chart of deep learning model for classification

2.3 Location-attention classification
The image classification model was designed to distinguish
the appearance and structure of different infections. Moreover,
relative distance-from-edge as the extra weight was used for
the model to learn the relative location information of the
patch on the pulmonary image. The focus of infections located
close to the pleura was more likely to be recognized as
COVID-19.
The relative distance-from-edge of each patch was calculated as follows:
1) Measure the minimum distance from the mask to the center of the patch.
2) Obtain the diagonal of the minimum circumscribed rectangle of the pulmonary image.
3) The relative distance-from-edge is the distance obtained
in step 1 divided by the diagonal from step 2.

2.4 Network structure
Two CNN three-dimensional classification models were evaluated in this study. One was a relative traditional ResNet23based network and the other model was designed based on the
first network structure by concatenating the location-attention
mechanism in the full-connection layer, to improve the overall
accuracy rate.
The classical ResNet-18 network structure was used for
image feature extraction (see Fig. 3). Pooling operations were
also used for the dimensional reduction of data to prevent
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Fig. 3 Network structure of the location-attention oriented model

overfitting and improve the problem of generalization. The
output of the convolution layer was flattened to a 256dimensional feature vector and then converted into a 16dimensional feature vector using a full-connection network.
For the location-attention network, the value of relative
distance-from-edge was first normalized to the same order of
magnitude and then concatenated to this full-connection network structure. Next, three full-connection layers were
followed to output the final classification result together with
the confidence score.

overfitting. The training curves of the loss value and the accuracy for two classification models are shown in Fig. 4. The
network with the location-attention mechanism achieved better performance on the training dataset compared with the
original ResNet.

3 Results
3.1 Performance on the test dataset

2.5 Training process
One of the most classical loss functions, cross-entropy, was
used in this study. When the epoch number of training iterations increased to more than 1000, the loss value did not decrease or increase obviously, suggesting that the models converged well to a relative optimal state without distinct

The accuracy of a method determines how correct the values
are predicted. The precision determines the reproducibility of
the measurement or how many of the predictions are correct.
Recall shows how many of the correct results are discovered.
F1-score uses a combination of precision and recall to calculate a balanced average result.
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Fig. 4 Training curve of loss and
accuracy for the two classification
models

Classification for a single image patch: a total of 1710 image
patches were acquired from 90 CTsamples, including 357 COVID19, 390 Influenza-A-viral-pneumonia, and 963 irrelevant-toinfection (ground truth). To determine which was the optimal approach, the design of each methodology was assessed using a confusion matrix. Two network structures were evaluated: with and
without the location-attention mechanism Table 2.
To summarize, using ResNet to extract features from CT
images together with a location-attention mechanism model,
compared to without the location-attention model, could more
accurately distinguish COVID-19 cases from others, with an
overall accuracy rate of 86.7%. Remarkably, it took on average less than 30s for a CT set (with 70 layers) from datapreprocessing to the output of the report.

4 Discussion
The RT-PCR test of 2019-nCoV RNA can make a definite
diagnosis of COVID-19 from Influenza-A viral pneumonia
Table 2

Predicted result

COVID-19
IAVP
NIF

Recall

Precision

f1score

0.867
0.833
0.900

0.813
0.862
0.931

0.839
0.847
0.915

patients. However, nucleic acid testing has some drawbacks
such as time lag, relatively low detection rate, and shortness of
supply. In the early stages of COVID-19, some patients may
already have positive pulmonary imaging findings but no sputum and hence get negative RT-PCR test results from nasopharyngeal swabs. These patients are not diagnosed as
suspected or confirmed cases, not isolated or treated, and become potential sources of infection.
The restrictions in movement and closing of the nonessential manufacturing industry in China has had a huge impact on its economy as well as supply-chain repercussions all
over the world. Now, with the worldwide spread of COVID19 at an alarming rate, other countries are also declaring an
emergency: taking measures such as the closing of schools,
restricting movement and urging remote-working (except for
essential workers e.g. nurses, doctors, care workers). It has
become increasingly clear even for Fortune 1000 companies,
that it is not going to be business-as-usual for the next couple
of months. Economists have warned that this pandemic could
cost $1.1 trillion in lost income globally (https://www.
dentons.com/en/insights/alerts/2020/march/11/covid-19-andits-impact-on-the-global-economy).
Whilst the WHO strongly recommends the testing of as
many suspects as possible, this has not been followed by many
countries seemingly due to a lack of resources/personnel as
well as a shortage of RT-PCR tests. Here, the use of CT imaging with AI could aid with the detection of COVID-19 by
providing a fast alternative and hence help limit the spread.
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CT images of COVID-19 cases present several distinct manifestations as discussed in section 1 (Introduction). However,
it is not objective or accurate to distinguish COVID-19 from
other diseases only with human eyes. In comparison, deep
learning system-based screening models, such as the one
reviewed here, have been proved to give specific and reliable
results by digitizing and standardizing the image information.

4.1 Limitations and further improvement
The deep learning model reviewed in this paper does allow
very fast and reliable detection of COVID-19 from chest CT
datasets (as shown in 3.2) and has a higher detection rate than
RT-PCR testing, however, a few other studies experimenting
with AI models recently, have obtained more promising rates
of detection. For example, one study developed on existing
2D and 3D deep-learning models, combining them with the
latest clinical understanding, and achieved an AUC of 0.996
(95%CI: 0.989–1.00) for Coronavirus vs Non-coronavirus
cases per thoracic CT studies. They calculated a sensitivity
of 98.2% and a specificity of 92.2% [8]. This system comprised of several components and analyzed each CT case at
two distinct levels: Subsystem A: 3D analysis of the case
volume for nodules and focal opacities (using a commercial
software called 3D lung volume from RADLogics Inc.) and
Subsystem B: newly developed 2D analysis of each slice of
the case to detect and localize larger-sized diffuse opacities
including ground glass infiltrates. Furthermore, they proposed
a Corona score: a volumetric measurement of the lung opacities, and an effective way to monitor patient progress over
time. This study performed much better than the one reviewed
in this paper, in terms of rate of detection, sensitivity, and
specificity, mainly because the system used was specifically
developed for the detection of COVID-19 manifestations.
Such fast and accurate analyses of CT datasets, as can only
be provided by optimized AI models, is crucial for front-line
clinicians screening patients during this pandemic.

4.2 Other approaches
New healthcare technologies are being implemented in the
fight against the novel coronavirus (COVID-19) outbreak in
China. This new tech includes artificial intelligence, analytics
software, and using drones to make deliveries to hospitals,
according to the healthcare market research firm GlobalData
(https://www.itnonline.com/article/emerging-technologiesproving-value-chinese-coronavirus-fight). The number of
deaths due to COVID-19 in China has already exceeded the
SARS outbreak in 2003. Against this backdrop, tech startups
are working with government agencies, clinicians and academics to help contain the outbreak. AI developer

Infervision launched a coronavirus artificial intelligence solution in China this past month that is tailored for front-line use
to help clinicians detect and monitor the disease more
effectively.
The GIS technology has become an important tool for stopping the spread of the coronavirus with John Hopkins
University leading the way in this area (https://
towardsdatascience.com/how-to-fight-the-coronavirus-withai-and-data-science-b3b701f8a08a, https://medium.com/@
ngocson2vn/build-an-artificial-neural-network-from-scratchto-predict-coronavirus-infection-8948c64cbc32). Data
mining is critical for GIS technology to work because of
using the information to detect areas where people talk about
the disease. Social media sites are good information sources
for GIS as the technology maps the area of interest where
people are talking about the coronavirus. Accordingly,
prevention measures can be implemented since these
heatmaps can better track both the location and the spread of
disease. Ten years ago, it was practically impossible to track
diseases; today, with AI, machine learning and GIS, data
mining and extracting insights are both easier and more
powerful at location viruses.
The bottom line: prevention response time is quicker today with the use of AI.
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